MADISON, Wis. -- Life science researchers can explore new ideas for genome engineering technology through a newly announced post-doctoral research program launched by Promega with mentoring support from AstraZeneca. The program gives researchers the unique opportunity to work on groundbreaking projects in an emerging field while collaborating with scientists at a global pharmaceutical company and [...]

Larger Field-of-View and Deep Imaging for In Vivo Neuroscience and Immuno-Oncology Research MADISON, Wisconsin – Bruker today announced the release of the Ultima Investigator Plus, the newest modular platform addition to the industry-leading Ultima line of multiphoton microscopes for deep tissue fluorescence imaging. With an expanded field of view, optimized optics for two- and three-photon imaging, [...]

VICTORIA, British Columbia -- IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to announce that it has entered into a definitive share purchase agreement (SPA) to acquire, through its wholly-owned subsidiary ImmunoPrecise Netherlands BV, control over BioStrand BV, BioKey BV, and BioClue BV (hereinafter collectively referred to as “ BioStrand ”), [...]

Funding will power a series of prospective clinical trials to validate Quanterix’ multi-analyte test in collaboration with Amsterdam University Medical Centers (Amsterdam UMC) Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has partnered with the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate [...]

Recently, China's leading company in animal cell culture technology and domestic serum-free culture media, Shanghai BioEngine Sci-Tech Co., LTD, announced the completion of a 200 million RMB Series B++ financing round. The financing was led by Legend Capital, followed by Addor Capital and Tsing Song Capital, and the old shareholder Hankang Capital continued to increase [...]

Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and Viking Transaction Closes Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting SOUTH SAN [...]

Fully silent Fc-engineered antibodies accessible for therapeutic antibody development Redcar and Oxford, UK: Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, and mAbsolve, developers of a novel Fc silencing variant, today announced a licensing deal for mAbsolve’s Fc silencing technology. The agreement provides Absolute Antibody clients with easy license-free access to the new [...]

MGI is pleased that the Court in the Northern District of California denied Illumina's request to overturn the jury's decision invalidating the '444 patent. The 444 patent was not set to expire until June 2023. Because the other patents Illumina asserted against MGI's CoolMPSTM technology expire in August 2022, MGI now has the ability to commercialize [...]

SEATTLE -- Curi Bio, a leading developer of human stem cell-based platforms and technologies for drug discovery, today announced the exclusive commercial acquisition from StemBioSys of the CarTox™ technology platform for calcium and voltage optical mapping. In parallel, Curi Bio announced it will commercialize the technology through its newly announced product: the Nautilus™ optical mapping system. By [...]

WALTHAM, MA - Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced it is the exclusive channel partner for AccuGenomics in the United States, with co-exclusive rights in Europe. Under the agreement, Fortis will help expand customer access to AccuGenomics’ patented SNAQ™-SEQ Internal [...]